4591 — Ribomic Share News
0.000.00%
Last trade - 00:00Brief: RIBOMIC in discussion to continue joint research with Otsuka Pharmaceutical on RBM001
Brief: Ribomic signs joint research agreement
Table: Ribomic -6-MTH parent results
Brief: Ribomic cooperates with Masaryk University on research of Achondroplasia treatment
Brief: Ribomic announces R& D on therapeutic aptamer against FGF2 jointly with three universities
Brief: Ribomic says substance patent assessment for anti-midkine aptamers in US
Table: Ribomic -Q1 parent results
Table: Ribomic -2015/16 parent results
Table: Ribomic -9-MTH parent results
Table: Ribomic -2015/16 parent forecast
Refile: TABLE-Ribomic -6-MTH parent results
Table: Ribomic -6-MTH parent results